History

A list of downloadable documents created during development.

Review proposal consultation

Background information

Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): final appraisal determination

Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): appraisal consultation document

Psoriatic arthritis - etanercept, infliximab and adalimumab: Final Assessment Report

Psoriatic arthritis - etanercept, infliximab, & adalimumab (review): final protocol

Psoriatic arthritis - etanercept, infliximab and adalimumab (review): Consultee and commentator comments on the draft scope, and the Institute's response

Psoriatic arthritis - etanercept, infliximab, golimumab and adalimumab (review): Final matrix of consultees and commentators

Psoriatic arthritis - etanercept, infliximab, golimumab and adalimumab (review): final scope

Psoriatic arthritis - etanercept, infliximab, golimumab and adalimumab (review): draft scope

Psoriatic arthritis - etanercept, infliximab, golimumab and adalimumab (review): provisional matrix of consultees and commentators

Psoriatic arthritis - etanercept, infliximab and adalimumab (review): update on scope

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis (review): draft scope

Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis (review): provisional matrix